Company · CIK 0002035832 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Aktis Oncology, Inc. · AKTS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 24, 4:05 pm EDT | Akos CzibereChief Medical Officer | 12,500 | $20.69 | $258,621 | 0 | −100% | 10b5-1 |
| Sep 23, 2026 MForm 4 → | Sep 24, 4:05 pm EDT | Akos CzibereChief Medical Officer | 12,500 | $4.95 | $61,875 | 12,500 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 MForm 4 → | Sep 24, 4:05 pm EDT | Akos CzibereChief Medical Officer | 12,500 | — | — | 208,718 | — | 10b5-1 |